Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, February 24, 2021
Eurofins Scientific has announced the acquisition of Beacon Discovery, a drug discovery and CRO focused on GPCR research.
read more
Eurofins Scientific has signed an exclusive agreement with Ekkio Capital to acquire the Amatsigroup for a price of approximately EUR 130m plus some residual debt at closing.
read more
Eurofins Scientific has signed an outsourcing agreement with Astellas to outsource one of its internal testing laboratories Astellas Analytical Science Laboratories.
read more
Tuesday, November 20, 2018
Eurofins has announced the company will distribute Synthego's synthetic single guide RNA (sgRNA) to their global customer database across 44 countries.
read more
Eurofins Scientific has announced plans to establish a new pharmaceutical chemistry and microbiology facility in Livingston, Scotland as part of a £4 million investment.
read more
Monday, February 09, 2026
Eurofins Viracor BioPharma Services announced a significant expansion of its service portfolio with the addition of enhanced bioanalytical testing capabilities.
read more
Monday, December 13, 2021
Clinical Enterprise, Inc., a Eurofins Scientific Company, has launched a new partnership with Ginkgo Bioworks to support Operation Expanded Testing Program with the U.S. Department of Health and Human Services and Department of Defense.
read more
Amgen on Tuesday received European approval for its first-of-a-kind cholesterol drug that lowers levels of the artery-clogging substance more than older drugs that have been prescribed for decades.
read more
Meribel Pharma Solutions has launched with ten manufacturing sites and three drug development services sites, situated across France, Spain and Sweden, following the acquisition of CDMO, Synerlab Group and seven European manufacturing facilities from...
read more
Wednesday, September 02, 2015
Novartis announced that the European Commission has approved Revolade® (eltrombopag) for the treatment of adults with severe aplastic anemia (SAA) who were either refractory to prior immunosuppressive therapy or heavily pretreated and are unsuitable ...
read more
The Board of the European Fine Chemicals Group (EFCG) announces that the 6th EFCG Annual Dinner will be held on 23rd October 2013 in Frankfurt at The InterContinental Hotel.
read more
The European Medicines Agency has released a draft policy on the publication and access to clinical-trial data for a three-month public consultation. Stakeholders have until 30 September 2013 to send their comments on the draft policy to the Agency.
read more
Wednesday, December 05, 2012
The European Medicines Agency today published a report highlighting the outcomes of the workshop on access to clinical-trial data and transparency which was hosted at the Agency on 22 November 2012.
read more
Friday, December 20, 2013
The European Medicines Agency (EMA) has now reviewed all comments received on its draft policy on publication and access to clinical trial data. While the comments received showed that there is large support for the Agency’s plans to allow access to ...
read more
Friday, November 21, 2014
The biotech sector in the Greater Munich area continues to demonstrate significant growth in revenue and staff numbers despite ever-increasing international competition. This continues Munich's status as one of the pre-eminent locations for this ...
read more